Free product worth Rs 499 on all myUpchar products
Mikasafe 500 Injection is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Urinary Tract Infection. The alternative uses of Mikasafe 500 Injection have also been explained below.
The optimal dosage of Mikasafe 500 Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Some other side effects of Mikasafe 500 Injection have been listed ahead. Usually, these side effects of Mikasafe 500 Injection go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Mikasafe 500 Injection is Severe for pregnant women and Unknown for women who are breastfeeding. In addition, Mikasafe 500 Injection's effects on the liver, heart and kidney are discussed below in the Mikasafe 500 Injection related warnings section.
Individuals suffering from medical conditions like Dehydration, Parkinson's Disease, Hearing Loss must refrain from the use of Mikasafe 500 Injection since this can cause severe adverse effects. The section on Mikasafe 500 Injection contraindications lists all such conditions.
Additionally, Mikasafe 500 Injection may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Mikasafe 500 Injection, it is important to know that it is safe while driving, and is habit-forming.
Mikasafe 500 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 2 - 12 years (Child) |
|
Is the use of Mikasafe 500 Injection safe for pregnant women?
Mikasafe can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Mikasafe 500 Injection safe during breastfeeding?
There is no research available on the side effects of Mikasafe in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Mikasafe 500 Injection on the Kidneys?
Consumption of Mikasafe can harm the kidneys. So it is important to take medical advice beforehand.
What is the effect of Mikasafe 500 Injection on the Liver?
Very few cases of side effects of Mikasafe on the liver have been reported.
What is the effect of Mikasafe 500 Injection on the Heart?
Side effects of Mikasafe rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Mikasafe 500 Injection unless your doctor advises you to do so -
Is this Mikasafe 500 Injection habit forming or addictive?
Mikasafe 500 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Mikasafe 500 Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Mikasafe 500 Injection only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Mikasafe 500 Injection for mental disorders.
Interaction between Food and Mikasafe 500 Injection
Taking Mikasafe 500 Injection with food does not cause any problems.
Interaction between Alcohol and Mikasafe 500 Injection
It is difficult to say anything about the effect of Mikasafe 500 Injection and alcohol. No research has been done on this yet.
Do not self-administer Mikasafe. It comes in the form of injection and given preferably 2 - 3 times in a day (Intravenously). Discontinuing the medicine in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 10 days course even after getting symptomatic relief. In case you feel any discomfort such as hearing loss and nephrotoxicity while taking Mikasafe please inform your doctor immediately.
Mikasafe is a broad-spectrum antibiotic which is active against both Gram-positive and Gram-negative bacteria. It works by preventing the synthesis of proteins that bacteria need to survive, in the absence of protein synthesis bacteria become vulnerable and dies. It is effective against different types of bacteria such as Escherichia coli, Proteus species, S. aureus, Acinetobacter and Serratia species.
Yes, Mikasafe has been reported to cause diarrhoea and it is a common side effect of this medicine. Drink plenty of fluids while you are taking this medicine. If you are experiencing severe diarrhoea after using this drug, discuss with your doctor immediately without any further delay.
Mikasafe is a brand name for amikacin. It is a prescription drug which belongs to the class of medication known as an aminoglycoside antibiotic. It is a broad spectrum antibiotic which is used for the treatment of bacterial infection such as bone, joint, skin, intra-abdominal, pneumonia, and respiratory tract infection. It is used for short-term treatment (7 - 10 days) of bacterial infection in different part of the body. It is also used for the treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.
Yes, Mikasafe is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as decreased urination, itching, irritation, and hearing loss. If you experience above-mentioned side after consuming this medicine then inform your doctor and follow his/her instructions.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
